Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)

China flag China · Delayed Price · Currency is CNY
4.050
-0.070 (-1.70%)
Apr 30, 2026, 3:00 PM CST
14.73%
Market Cap 3.23B
Revenue (ttm) 1.72B
Net Income (ttm) -349.70M
Shares Out 784.39M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 37,857,559
Average Volume 116,644,179
Open 4.090
Previous Close 4.120
Day's Range 4.040 - 4.150
52-Week Range 3.440 - 5.270
Beta 0.30
RSI 42.54
Earnings Date Apr 23, 2026

About SHA:600594

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology. The company also engages in investme... [Read more]

Sector Healthcare
Founded 1995
Employees 5,261
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600594
Full Company Profile

Financial Performance

In 2025, SHA:600594's revenue was 1.86 billion, a decrease of -14.31% compared to the previous year's 2.17 billion. Losses were -329.56 million, 3.89% more than in 2024.

Financial Statements

News

There is no news available yet.